GNANI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 366
EU - Europa 351
AS - Asia 299
AF - Africa 28
SA - Sud America 11
Totale 1.055
Nazione #
US - Stati Uniti d'America 360
CN - Cina 115
SG - Singapore 99
GB - Regno Unito 95
SE - Svezia 66
IT - Italia 42
DE - Germania 32
FR - Francia 20
IN - India 19
VN - Vietnam 18
KR - Corea 17
HK - Hong Kong 15
NL - Olanda 15
GR - Grecia 13
IE - Irlanda 13
UA - Ucraina 12
CH - Svizzera 11
RU - Federazione Russa 10
ZA - Sudafrica 9
BR - Brasile 8
CI - Costa d'Avorio 7
BE - Belgio 6
BG - Bulgaria 5
FI - Finlandia 5
JO - Giordania 5
TG - Togo 5
CA - Canada 4
EE - Estonia 4
NG - Nigeria 4
IR - Iran 3
PH - Filippine 3
SC - Seychelles 3
PL - Polonia 2
TR - Turchia 2
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
IQ - Iraq 1
JP - Giappone 1
PA - Panama 1
SR - Suriname 1
SV - El Salvador 1
Totale 1.055
Città #
Southend 85
Singapore 69
Chandler 49
Hefei 46
Ashburn 34
Fairfield 30
Woodbridge 21
Ann Arbor 18
Cambridge 16
Houston 16
Wilmington 16
Hong Kong 15
Seoul 15
Beijing 14
Princeton 14
Dublin 13
New York 10
Seattle 10
Bern 9
Boardman 9
Dallas 8
Westminster 8
Abidjan 7
Bologna 7
Brussels 6
Ho Chi Minh City 6
Jacksonville 6
Padova 6
Santa Clara 6
Turin 6
Amman 5
Buffalo 5
Helsinki 5
Lomé 5
Medford 5
Milan 5
Sofia 5
Bengaluru 4
Hebei 4
Nanjing 4
Falkenstein 3
Grafing 3
Hanoi 3
San Diego 3
Shenyang 3
Abeokuta 2
Athens 2
Bremen 2
Davao City 2
Dearborn 2
Frankfurt am Main 2
Istanbul 2
Jinan 2
Johannesburg 2
Kish 2
Los Angeles 2
Ninh Bình 2
North York 2
Orem 2
Quận Bình Thạnh 2
Riolo Terme 2
Tongling 2
Vicenza 2
Warsaw 2
Amsterdam 1
Andover 1
Baghdad 1
Bakhchysarai 1
Baku 1
Berlin 1
Biên Hòa 1
Boston 1
Brasília 1
Brooklyn 1
Cape Town 1
Caçapava 1
Cesenatico 1
Changsha 1
Chengdu 1
Chennai 1
Chicago 1
Dongguan 1
Falls Church 1
Firmat 1
Groningen 1
Guangzhou 1
Haikou 1
Haiphong 1
Hà Nam Province 1
Hải Dương 1
Inhoaíba 1
Jiaozuo 1
Jiaxing 1
Khabarovsk 1
Kilburn 1
Las Vegas 1
Lausanne 1
Leawood 1
Long An 1
Maceió 1
Totale 711
Nome #
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 315
Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience 240
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia 162
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients 129
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology 124
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib 104
Totale 1.074
Categoria #
all - tutte 2.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 3 0 11 10 5 3 7
2021/2022151 8 2 11 16 14 13 3 10 10 10 25 29
2022/2023172 18 35 7 23 9 14 5 7 30 0 13 11
2023/202446 0 9 3 5 4 15 3 0 2 1 3 1
2024/2025149 10 9 13 10 18 3 8 6 1 16 13 42
2025/2026221 42 50 42 28 48 11 0 0 0 0 0 0
Totale 1.074